Whitefort Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Roivant Sciences
ROIV
|
+$8.63M |
| 2 |
Genworth Financial
GNW
|
+$3M |
| 3 |
Global Ship Lease
GSL
|
+$1.62M |
| 4 |
Liquidia Corp
LQDA
|
+$1.47M |
| 5 |
INNOVATE Corp
VATE
|
+$794K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NextNav
NN
|
+$5.9M |
| 2 |
CEE
Central and Eastern Europe Fund
CEE
|
+$2.97M |
| 3 |
ESPR
Esperion Therapeutics
ESPR
|
+$2.65M |
| 4 |
Arbutus Biopharma
ABUS
|
+$867K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 38.7% |
| 2 | Industrials | 26.28% |
| 3 | Financials | 10.63% |
| 4 | Technology | 5.16% |
| 5 | Communication Services | 3.04% |
Similar funds
Whitefort Capital Management's Q1 2024 Portfolio in Review
As of Q1 2024, Whitefort Capital Management held 21 positions worth $164M, up 4.7% from $157M the previous quarter. Its ten largest holdings account for 93% of the portfolio.
Whitefort Capital Management withdrew a net $6.98M in Q1 2024, closing 2 positions and reducing 3 holdings. Its most notable exit was Central and Eastern Europe Fund, an estimated $2.97M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 39% of assets, up from 36% a quarter earlier, followed by Industrials and Financials.
Against the trend, Whitefort Capital Management added an estimated $8.63M to Roivant Sciences.
- Whitefort Capital Management added most to Roivant Sciences in Q1 2024, an estimated $8.63M increase.
- Whitefort Capital Management's biggest Q1 2024 reduction was NextNav, cutting an estimated $5.9M.
- Whitefort Capital Management fully exited Central and Eastern Europe Fund in Q1 2024, selling an estimated $2.97M.
- Whitefort Capital Management's ten largest holdings make up 93% of its $164M portfolio in Q1 2024.
- Whitefort Capital Management opened 0 new positions and closed 2 in Q1 2024.
- Whitefort Capital Management's portfolio value rose 4.7% quarter-over-quarter to $164M.
Based on Whitefort Capital Management's 13F filing for Q1 2024, filed 15 May 2024.